Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04774328 · ClinicalTrials.gov registry record · Phase 1
Preliminary Study of CA-008 (Vocacapsaicin) in Patients Undergoing Ventral Hernia Repair
A Phase 1 study, sponsored by Concentric Analgesics.
- Completed
- Registry status
- Phase 1
- Development phase
- 34
- Enrollment target
NCT04774328 is a Phase 1 study that has completed, run by Concentric Analgesics. The registered enrollment target is 34 participants.
The verdict
NCT04774328, a Phase 1 study, has completed, sponsored by Concentric Analgesics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 34 participants
- Enrollment target
Study Summary
A Three-Part, Phase 1/2, Randomized, Double-blind, Placebo-Controlled, Adaptive Safety, Pharmacokinetics, and Preliminary Efficacy Study of CA-008 (Vocacapsaicin) in Patients Undergoing Ventral Hernia Repair
Interventions
- DRUG Placebo
- DRUG CA-008 (vocacapsaicin)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2020-09-09 |
| Est. Completion | 2021-06-15 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04774328
The ClinicalTrials.gov registry entry for NCT04774328 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Concentric Analgesics, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04774328 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04774328 about?
NCT04774328 is a clinical study titled "Preliminary Study of CA-008 (Vocacapsaicin) in Patients Undergoing Ventral Hernia Repair". A Three-Part, Phase 1/2, Randomized, Double-blind, Placebo-Controlled, Adaptive Safety, Pharmacokinetics, and Preliminary Efficacy Study of CA-008 (Vocacapsaicin) in Patients Undergoing Ventral Hernia Repair
What is the current status of trial NCT04774328?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 34 participants. The study started on 2020-09-09. Estimated completion is 2021-06-15.
What interventions are being tested in trial NCT04774328?
The interventions under investigation include: Placebo (DRUG), CA-008 (vocacapsaicin) (DRUG).
Who is sponsoring clinical trial NCT04774328?
This trial is sponsored by Concentric Analgesics, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.